Clinical Trial Update: A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 study evaluating pomalidomide with low-dose dexamethasone in relapsed/refractory multiple myeloma is being conducted; final results are not provided in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Dexamethasone (low-dose) (dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Multiple Myeloma, Recurrent or Refractory | Phase 3 | Status: UNKNOWN